Genesis Healthcare, Inc.
GEN
GEN was delisted on the 25th of March, 2021.
1 hedge funds and large institutions have $0 invested in Genesis Healthcare, Inc. in 2024 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
50% less funds holding
Funds holding: 2 → 1 (-1)
100% less capital invested
Capital invested by funds: $11 → $0 (-$11)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WPW
Waldron Private Wealth
Bridgeville,
Pennsylvania
|
-$11 |
GEN Hedge Fund Activity: Q3 2024 in Review
1 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Genesis Healthcare, Inc. (GEN) for Q3 2024, worth a combined $0 — down 100% from $11 a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of GEN and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Waldron Private Wealth, exiting entirely with an estimated $11 sold.
- 1 institutional investor held Genesis Healthcare, Inc. (GEN) as of Q3 2024, down from 2 in Q2 2024.
- Funds reported $0 of Genesis Healthcare, Inc. stock for Q3 2024, down 100% quarter-over-quarter.
- 0 funds opened new Genesis Healthcare, Inc. positions in Q3 2024 and 1 closed out, a net change of -1 holder.
- The largest Genesis Healthcare, Inc. seller in Q3 2024 was Waldron Private Wealth, an estimated $11 sold.
Based on aggregated 13F filings for Q3 2024.